AstraZeneca Can't Dodge Nexium Antitrust Claims
By Emily Atkin ( September 12, 2013, 9:38 PM EDT) -- A Massachusetts federal judge Wednesday largely kept intact multidistrict litigation brought by direct- and third-party purchasers that allege AstraZeneca PLC and several generic-drug makers violated antitrust laws by entering into agreements to delay entry of a generic version of AstraZeneca's heartburn drug Nexium....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.